Dr. Barbara A. Vance to Join Sylvester as Assistant VP and Associate Director for Administration
Barbara A. Vance, Ph.D., CRA, will join Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine on March 17 as assistant vice president and associate director for administration. In that role, Vance will be a senior member of Sylvester’s leadership team, responsible for efficient operations and financial performance, including submission of the National Cancer Institute (NCI) Cancer Center Support Grant.
Vance will have direct oversight and responsibility for strategic planning, finances, grant administration, clinical research administration, shared resources, membership, faculty recruitment, space planning, human resources administration, education and training.
“Dr. Vance brings a broad range of expertise to Sylvester,” said Stephen D. Nimer, M.D., Sylvester’s director. “She is a collaborative team player across many functions, with extensive experience supervising service cores, pilot project programs and clinical trials management systems. She also is an effective communicator, with impressive experience lobbying state and local officials to support research. I am delighted to welcome her to Sylvester, and I know that she will make many important contributions to our continued growth and success.”
Vance joins Sylvester from the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania in Philadelphia, where she has been administrative director for science and technology since 2015.
“Dr. Nimer and the outstanding physicians and scientists he has recruited to Miami have built a world-class cancer center, and I look forward to joining them,” said Vance. “South Florida’s extremely diverse population offers significant clinical challenges, and Sylvester’s ongoing research will improve our ability to match the best, most effective treatment with each patient. The continued recognition of Sylvester’s expertise — especially the anticipated NCI designation — will open up exciting new national and international opportunities for collaborative research and clinical trials.”
Vance’s earlier professional roles include executive director for administration at Perlmutter Cancer Center at the NYU Langone Medical Center in New York City, and associate director for research administration at Abramson Cancer Center at the University of Pennsylvania, where she has also been an adjunct assistant professor of cancer biology since 2003.
Her academic credentials include a Ph.D. from the Dartmouth College School of Medicine, M.S. and B.S. degrees in physiology and biochemistry, respectively, from The Ohio State University, and a certification in research administration from the Research Administrators Certification Council. In addition, she has conducted her own research and published 22 peer-reviewed articles in a broad range of scientific disciplines, including electrophysiology, cellular immunology, molecular biology and protein biochemistry.